Medical therapy for gallstones. 1. Rationale and indications.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D001647:Bile Acids and Salts / Q000502:physiology; D001652:Bile Ducts / Q000601:surgery; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000188:drug therapy* / Q000601:surgery; D048909:Diabetes Complications; D005260:Female; D006801:Humans; D009765:Obesity / Q000150:complications; D010713:Phosphatidylcholines / Q000502:physiology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D001647:Bile Acids and Salts; D010713:Phosphatidylcholines; D002635:Chenodeoxycholic Acid; D014580:Ursodeoxycholic Acid